Abstract:Background: Flavones are potential anticancer agents that act by different mechanisms and have multiple targets to exert anticancer effects. Nitrogen-containing heterocyclic rings have remarkable chemical characteristics as well as a wide range of biological activities. Substitution of the N-heterocyclic ring on the flavon structure may potentiate its anticancer effect. background: Flavones are potential anticancer agents that act by different mechanisms and have multiple targets to produce anticancer effects. Nitrogen-containing heterocyclic rings have remarkable chemical characteristics as well as a wide range of biological activity. Substitution of the N-heterocyclic ring on the flavon structure may potentiate its anticancer effect. Objective: A series of flavon derivatives with an N-heteroaryl ring at the 4' position of the B ring of flavon were designed, prepared, and evaluated for anticancer activity. Method: Different flavon derivatives were created by cyclizing chalcones, and chalcones were synthesized by Claisen-Schmidt condensation of substituted aldehydes and 2-hydroxyacetophenone. Structures of all compounds were confirmed by 1HNMR, 13CNMR, FTIR, and MS spectra. Molecular docking was used to study the binding interactions of the synthesized compounds with the multiple targets ER-α, EGFR, and VEGFR-2. Anticancer activity was evaluated by Brine shrimp assay, MTT assay, and SRB assay on breast cancer (MCF-7, MDA-MB-231, and MDA-MB-468) and cervical cancer (HeLa). An apoptosis study was carried out on MCF-7 cell lines for the active compounds. Results: Among all compounds, 6c and 5f showed potent growth inhibition of ER-positive breast cancer cell lines. Compounds 5b, 5c, 5g, and 6f displayed good anticancer activity against cervical cancer. In triple-negative breast cancer cell lines, compounds 5c, 6b, and 6c showed remarkable anticancer activity. The potent flavones identified against breast cancer cell lines were 5f and 6c. Anticancer study results were analogous to the results obtained by the molecular docking study. Conclusion: This study offers a viable reference point for improving the design of flavon-incorporated N-heterocyclic ring derivatives as anticancer compounds.

Design And Synthesis Of Flavonoidal Ethers And Their Anti-Cancer Activity In Vitro

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis, Molecular Docking, and Anticancer Activity of N-Heteroaryl Substituted Flavon Derivatives

Design, Synthesis and Activity of Flavonoids Aromatase Inhibitors

Synthesis and Biological Activity of Flavanone Derivatives

Design, Synthesis and 3D-QSAR Study of Cytotoxic Flavonoid Derivatives.

Investigation on the Substitution Effects of the Flavonoids As Potent Anticancer Agents: a Structure–activity Relationships Study

Synthesis and Structure Characterization of Bioactive Polymethoxyflavonoids Glycosides

Synthesis and Antiproliferative Activities of Aminoalkylated Polymethoxyflavonoid Derivatives

Design, synthesis and biological evaluation of 3',4',5'-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents.

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Discovery of a Potential Multi-Target Anti-Tumor Agent Via Structural Modification on Flavonoid

Synthesis and Anti-Proliferative Activities of 5,6,7-Trimethoxyflavones and Their Derivatives

Design and Synthesis of the Novel Oleanolic Acid-Cinnamic Acid Ester Derivatives and Glycyrrhetinic Acid-Cinnamic Acid Ester Derivatives with Cytotoxic Properties

Design, Synthesis and Biological Evaluation of 3-Benzylideneflavanone Derivatives As Cytotoxic Agents

Synthesis and Antiproliferative Activity of Novel Aminoalkylated Flavones

Studies of the Synthesis and the Structure-activity Relationship of 3-Methylflavones

Synthesis and Biological Activity of Novel Flavonoids Galactoconjugates

Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents

Synthesis and in vitro exploration of the 8-carbo substituted 5-methoxyflavones as anti-breast and anti-lung cancer agents targeting protein kinases (VEGFR-2 & EGFR)

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay